GALECTIN THERAPEUTICS INC (GALT) Interest Expense USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Galectin Therapeutics Inc quarterly/annual Interest Expense history and growth rate from 2018 to 2024.
  • Galectin Therapeutics Inc Interest Expense for the quarter ending March 31, 2024 was $1.05 M, a 129% increase year-over-year.
  • Galectin Therapeutics Inc Interest Expense for the twelve months ending March 31, 2024 was $3.38 M, a 167% increase year-over-year.
  • Galectin Therapeutics Inc annual Interest Expense for 2023 was $2.79 M, a 170% increase from 2022.
  • Galectin Therapeutics Inc annual Interest Expense for 2022 was $1.03 M, a 111% increase from 2021.
  • Galectin Therapeutics Inc annual Interest Expense for 2021 was $489 K, a 462% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $3.38 M $1.05 M +$592 K +129% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $2.79 M $847 K +$539 K +175% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 $2.25 M $835 K +$566 K +210% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $1.69 M $650 K +$421 K +184% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $1.27 M $460 K +$233 K +103% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $1.03 M $308 K +$37 K +13.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 $996 K $269 K +$158 K +142% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $838 K $229 K +$144 K +169% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $694 K $227 K +$205 K +932% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $489 K $271 K +$249 K +1132% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $240 K $111 K +$89 K +405% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $151 K $85 K +$64 K +305% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $87 K $22 K $0 0% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $87 K $22 K $0 0% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $87 K $22 K $0 0% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $87 K $21 K $0 0% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $87 K $22 K $0 0% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $87 K $22 K -$58 K -72.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 $145 K $22 K -$65 K -74.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $210 K $21 K -$64 K -75.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $274 K $22 K -$62 K -73.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $336 K $80 K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 $87 K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $85 K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $84 K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.